References
- Egalini F, Marinelli L, Rossi M, Motta G, Prencipe N, Rossetto Giaccherino R, Pagano L, Grottoli S, Giordano R. Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands. Endocrine 2022;78:395–405. doi: 10.1007/s12020-022-03076-x
- European Union. Document 52019IP0441. European Parliament resolution of 18 April 2019 on a comprehensive European Union framework on endocrine disruptors (2019/2683(RSP)) [displayed 12 March 2025]. Available at
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52019IP0441 - European Union. Document 52018DC0734. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Towards a comprehensive European Union framework on endocrine disruptors COM/2018/734 final [displayed 12 March 2025]. Available at
https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1553617067256&uri=CELEX:52018DC0734 - Shanle EK, Xu W. Endocrine disrupting chemicals targeting estrogen receptor signaling: Identification and mechanisms of action. Chem Res Toxicol 2011;24:6–19. doi: 10.1021/tx100231n
- Ahn C, Jeung EB. Endocrine-disrupting chemicals and disease endpoints. Int J Mol Sci 2023;24:5342. doi: 10.3390/ijms24065342
- Gore AC, La Merrill MA, Patisaul H, Sargis RM. Endocrine Disrupting Chemicals: Threats to Human Health. The Endocrine Society and IPEN, 2024.
- Hilz EN, Gore AC. Endocrine-disrupting chemicals: science and policy. Policy Insights Behav Brain Sci 2023;10:142–50. doi: 10.1177/23727322231196794
- OECD. Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals, 2023 [displayed 12 March 2025]. Available at
https://doi.org/10.1787/9789264264366-en - OECD. Test No. 455: Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists [displayed 12 March 2025]. Available at
https://www.oecd.org/en/publications/test-no-455-performance-based-test-guideline-for-stably-transfectedtransactivation-in-vitro-assays-to-detect-estrogen-receptor-agonistsand-antagonists_9789264265295-en.html - Tijani JO, Fatoba OO, Babajide OO, Petrik LF. Pharmaceuticals, endocrine disruptors, personal care products, nanomaterials and perfluorinated pollutants: a review. Environ Chem Lett 2016;14:27–49. doi: 10.1007/s10311-015-0537-z
- Roig B, Mnif W, Hadj Hassine AI, Zidi I, Bayle S, Bartegi A, Thomas O. Endocrine disrupting chemicals and human health risk assessment: A critical review. Crit Rev Environ Sci Technol 2013;43:2297–351. doi: 10.1080/10643389.2012.672076
- Mancebo SE, Hu JY, Wang SQ. Sunscreens: A review of health benefits, regulations, and controversies. Dermatol Clin 2014;32:427–38. doi: 10.1016/j.det.2014.03.011
- ECHA. Substance Infocard Oxybenzone [displayed 12 March 2025]. Available at
https://echa.europa.eu/hr/substance-information/-/substanceinfo/100.004.575 - Krause M, Frederiksen H, Sundberg K, Jørgensen FS, Jensen LN, Nørgaard P, Jørgensen C, Ertberg P, Juul A, Drzewiecki KT, Skakkebaek NE, Andersson AM. Presence of benzophenones commonly used as UV filters and absorbers in paired maternal and fetal samples. Environ Int 2018;110:51–60. doi: 10.1016/j.envint.2017.10.005
- Matta MK, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Florian J, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong LA, Ganley C, Michele T, Strauss DG. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: A randomized clinical trial. JAMA 2019;321:2082–91. doi: 10.1001/jama.2019.5586
- Iribarne-Durán LM, Serrano L, Peinado FM, Peña-Caballero M, Hurtado JA, Vela-Soria F, Fernández MF, Freire C, Artacho-Cordón F, Olea N. Biomonitoring bisphenols, parabens, and benzophenones in breast milk from a human milk bank in Southern Spain. Sci Total Environ 2022;830:154737. doi: 10.1016/j.scitotenv.2022.154737
- Scientific Committee on Consumer Safety (SCCS). Opinion on Benzophenone-3 (CAS No 131-57-7, EC No 205-031-5), 2021 [displayed 12 March 2025]. Available at
https://health.ec.europa.eu/system/files/2022-08/sccs_o_247.pdf - Gomez Cortes L, Porcel Rodriguez E, Marinov D, Sanseverino I, Lettieri T. Selection of substances for the 5th Watch List under the Water Framework Directive, 2025 [displayed 12 March 2025]. Available at
https://op.europa.eu/en/publication-detail/-/publication/a531a7ff-d3b9-11ef-be2a-01aa75ed71a1/language-en - Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. Int J Toxicol 2008;27(Suppl. 4):1–82. doi: 10.1080/10915810802548359
- Barr L, Metaxas G, Harbach CAJ, Savoy LA, Darbre PD. Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum. J Appl Toxicol 2012;32:219–32. doi: 10.1002/jat.1786
- Parla A, Zormpa E, Paloumpis N, Kabir A, Furton KG, Roje Ž, Samanidou V, Vinković Vrček I, Panderi I. Determination of intact parabens in the human plasma of cancer and non-cancer patients using a validated fabric phase sorptive extraction reversed-phase liquid chromatography method with uv detection. Molecules 2021;26(6):1526. doi: 10.3390/molecules26061526
- Sandanger TM, Huber S, Moe MK, Braathen T, Leknes H, Lund E. Plasma concentrations of parabens in postmenopausal women and self-reported use of personal care products: The NOWAC postgenome study. J Expo Sci Environ Epidemiol 2011;21:595–600. doi: 10.1038/jes.2011.22
- Vela-Soria F, Rodríguez I, Ballesteros O, Zafra-Gómez A, Ballesteros L, Cela R, Navalón A. Simplified matrix solid phase dispersion procedure for the determination of parabens and benzophenone-ultraviolet filters in human placental tissue samples. J Chromatogr A 2014;1371:39–47. doi: 10.1016/j.chroma.2014.10.063
- Vo TTB, Yoo YM, Choi KC, Jeung EB. Potential estrogenic effect(s) of parabens at the prepubertal stage of a postnatal female rat model. Reprod Toxicol 2010;29:306–16. doi: 10.1016/j.reprotox.2010.01.013
- Kjærstad MB, Taxvig C, Andersen HR, Nellemann C. Mixture effects of endocrine disrupting compounds in vitro. Int J Androl 2010;33:425–33. doi: 10.1111/j.1365-2605.2009.01034.x
- Scientific Committee on Consumer Safety (SCCS). Opinion on Methylparaben (CAS No. 99-76-3, EC No. 202-785-7), 2023 [displayed 12 March 2025]. Available at
https://health.ec.europa.eu/document/download/eb3192aa-089c-4fcf-8cac-b34892dd0b3e_en?filename=sccs_o_276_final.pdf - ECHA. Substance Infocard Methyl 4-hydroxybenzoate [displayed 12 March 2025]. Available at
https://echa.europa.eu/hr/substance-information/-/substanceinfo/100.002.532 - ECHA. Endocrine disruptor assessment list [displayed 12 March 2025]. Available at
https://echa.europa.eu/hr/ed-assessment/-/dislist/details/0b0236e180765a65 - Zwart N, Andringa D, de Leeuw WJ, Kojima H, Iida M, Houtman CJ, de Boer J, Kool J, Lamoree MH, Hamers T. Improved androgen specificity of AR-EcoScreen by CRISPR based glucocorticoid receptor knockout. Toxicol in Vitro 2017;45:1–9. doi: 10.1016/j.tiv.2017.08.004
- Chen J, Ahn KC, Gee NA, Gee SJ, Hammock BD, Lasley BL. Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol Appl Pharmacol 2007;221:278–84. doi: 10.1016/j.taap.2007.03.015
- Ma R, Cotton B, Lichtensteiger W, Schlumpf M. UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol Sci 2003;74:43–50. doi: 10.1093/toxsci/kfg102
- Roje Ž, Ilić K, Galić E, Pavičić I, Turčić P, Stanec Z, Vinković Vrček I. Synergistic effects of parabens and plastic nanoparticles on proliferation of human breast cancer cells. Arh Hig Rada Toksikol 2019;70:310–4. doi: 10.2478/aiht-2019-70-3372
- Chi Rim Sung, Byeong Jun Kim, Chan Ju Park, In Ah Oh, Yu Jin Lee, Yeo Rim Park SJK. Evaluation of the anti-androgenic and cytotoxic effects of benzophenone-3 in male Sprague-Dawley rats. J Toxicol Enviromental Heal A 2024;87:266–73. doi: 10.1080/15287394.2023.2300785
- Kunz PY, Galicia HF, Fent K. Comparison of in vitro and in vivo estrogenic activity of UV filters in fish. Toxicol Sci 2006;90:349–61. doi: 10.1093/toxsci/kfj082
- Sun L, Yu T, Guo J, Zhang Z, Hu Y, Xiao X, Li J, Zhu D, Sai L, Li J. The estrogenicity of methylparaben and ethylparaben at doses close to the acceptable daily intake in immature Sprague-Dawley rats. Sci Rep 2016;6(1):25173. doi: 10.1038/srep25173
- Okubo T, Yokoyama Y, Kano K, Kano I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERα and PR. Food Chem Toxicol 2001;39:1225–32. doi: 10.1016/s0278-6915(01)00073-4
- Payne J, Jones C, Lakhani S, Kortenkamp A. Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Sci Total Environ 2000;248:51–62. doi: 10.1016/s0048-9697(99)00479-9
- Liang J, Liu QS, Ren Z, Min K, Yang X, Hao F, Zhang Q, Liu Q, Zhou Q, Jiang G. Studying paraben-induced estrogen receptor- and steroid hormone-related endocrine disruption effects via multi-level approaches. Sci Total Environ 2023;869:161793. doi: 10.1016/j.scitotenv.2023.161793